nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A Response to: Letter to the Editor Regarding Long-Term Benefit–Risk Profiles of Treatments for Moderate-to-Severe Plaque Psoriasis: A Network Meta-analysis
|
Armstrong, April W. |
|
|
12 |
12 |
p. 2867-2870 |
artikel |
2 |
A Review of the Clinical Trial Landscape in Psoriasis: An Update for Clinicians
|
Drakos, Anastasia |
|
|
12 |
12 |
p. 2715-2730 |
artikel |
3 |
Artificial Intelligence in Dermatology: Challenges and Perspectives
|
Liopyris, Konstantinos |
|
|
12 |
12 |
p. 2637-2651 |
artikel |
4 |
Burden of Atopic Dermatitis in Adults and Adolescents: a Systematic Literature Review
|
Fasseeh, Ahmad N. |
|
|
12 |
12 |
p. 2653-2668 |
artikel |
5 |
Characteristics of Giant Nodular Melanomas in Special Locations: a Case Series and Review of the Literature
|
Kamińska-Winciorek, Grażyna |
|
|
12 |
12 |
p. 2851-2862 |
artikel |
6 |
Commentary on a Clinical Trial of Spesolimab, a Humanized Anti-interleukin-36 Receptor Monoclonal Antibody, in Generalized Pustular Psoriasis
|
Shao, Shuai |
|
|
12 |
12 |
p. 2627-2635 |
artikel |
7 |
Correction to: Leg Ulcer Therapy by Local Injection of Autologous Growth Factors: Results of a Pilot Study
|
Šíma, Petr |
|
|
12 |
12 |
p. 2871 |
artikel |
8 |
Current and Emerging Therapies in Pediatric Atopic Dermatitis
|
Johnson, Hadley |
|
|
12 |
12 |
p. 2691-2703 |
artikel |
9 |
Determining Severity Strata for Three Atopic Dermatitis Patient-Reported Outcome Questionnaires: Defining Severity Score Ranges for the Worst Pruritus Numerical Rating Scale and the Atopic Dermatitis Symptom and Impact Scales (ADerm-SS and ADerm-IS)
|
Silverberg, Jonathan I. |
|
|
12 |
12 |
p. 2817-2827 |
artikel |
10 |
Development, Psychometric Validation and Responder Definition of Worst Itch Scale in Children with Severe Atopic Dermatitis
|
Paller, Amy S. |
|
|
12 |
12 |
p. 2839-2850 |
artikel |
11 |
Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis is Efficacious Regardless of Age of Disease Onset: a Post Hoc Analysis of Two Phase 3 Clinical Trials
|
Silverberg, Jonathan I. |
|
|
12 |
12 |
p. 2731-2746 |
artikel |
12 |
Hyperhidrosis: A Review of Recent Advances in Treatment with Topical Anticholinergics
|
Wong, Nikita S. |
|
|
12 |
12 |
p. 2705-2714 |
artikel |
13 |
Letter to the Editor Regarding Long-Term Benefit–Risk Profiles of Treatments for Moderate-to-Severe Plaque Psoriasis: A Network Meta-analysis
|
Pettitt, Dan |
|
|
12 |
12 |
p. 2863-2866 |
artikel |
14 |
Maintenance and Concomitant Therapy Use with Chlormethine Gel Among Patients with Stage IA/IB Mycosis Fungoides-Type Cutaneous T-Cell Lymphoma (MF-CTCL): A Real-World Evidence Study
|
Querfeld, Christiane |
|
|
12 |
12 |
p. 2781-2795 |
artikel |
15 |
Multidisciplinary Rheuma–Derma Clinics: 5 Years of Experience at the San Marco Hospital in Catania
|
Foti, Rosario |
|
|
12 |
12 |
p. 2829-2837 |
artikel |
16 |
New Developing Treatments for Molluscum Contagiosum
|
Lacarrubba, Francesco |
|
|
12 |
12 |
p. 2669-2678 |
artikel |
17 |
Outcomes in Ixekizumab Patients Following Exposure to Secukinumab and Other Biologics in the CorEvitas Psoriasis Registry
|
Lockshin, Benjamin |
|
|
12 |
12 |
p. 2797-2815 |
artikel |
18 |
Pooled Safety Analysis of Baricitinib in Adult Participants with Atopic Dermatitis in the Japanese Subpopulation from Six Randomized Clinical Trials
|
Katoh, Norito |
|
|
12 |
12 |
p. 2765-2779 |
artikel |
19 |
Predicting Clinical Remission of Chronic Urticaria Using Random Survival Forests: Machine Learning Applied to Real-World Data
|
Pivneva, Irina |
|
|
12 |
12 |
p. 2747-2763 |
artikel |
20 |
The Impact of Global Health Disparities on Atopic Dermatitis in Displaced Populations: Narrowing the Health Equity Gap for Patients with Skin of Color
|
Jelousi, Sami |
|
|
12 |
12 |
p. 2679-2689 |
artikel |